Open
SectorHealthcare
0.32 -11.11
24h
Min
0.3
Max
0.36
Income | -2.6M -14M |
---|---|
Sales | 3.8M 16M |
EPS | -0.11 |
Profit margin | -86.284 |
Employees | 102 |
EBITDA | -1.1M -13M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +1223.53% upside |
Next Earnings | 8 May 2025 |
---|
Market Cap | -12M 47M |
---|---|
Previous open | 11.43 |
Previous close | 0.32 |
By Acuity
50%
50%
180 / 386 Healthcare
By Trading Central
Confidence
Neutral Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 4.5 USD 1223.53%
High 6 USD
Low 3 USD
Based on 7 Wall Street analysts offering 12 month price targets forMersana Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$